Benzylpiperazine: the New Zealand legal perspective.

Tools

BASSINDALE, Thomas (2011). Benzylpiperazine: the New Zealand legal perspective. Drug Testing and Analysis, 3 (7-8), 428-429. [Article]

Abstract
In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed.
More Information
Research Institute, Centre or Group - Does NOT include content added after October 2018:
Biomedical Research Centre
Page Range:
428-429

Identifiers

Identification Number:
10.1002/dta.314
ORCID for Thomas Bassindale: ORCID iD orcid.org/0000-0002-4023-6478

Library

Item Type:
Article
Depositing User:
Rebecca Jones
Date Deposited:
08 Feb 2012 17:01
Last Modified:
18 Mar 2021 20:30
URI:
https://shura.shu.ac.uk/id/eprint/4495
Metrics

Altmetric Badge

Dimensions Badge

Share
Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Actions (login required)

View Item View Item

SHURA supports OAI 2.0 with a base URL of https://shura.shu.ac.uk/cgi/oai2